Back
Minerva Neurosciences Vs. Calidi Biotherapeutics Industry Stock Comparison
Sell
42
NERV
Minerva Neurosciences
Last Price:
2.55
Seasonality Move:
6.86%
Buy
56
CLDI
Calidi Biotherapeutics
Last Price:
0.23
Seasonality Move:
1.49%
Sell
42
Minerva Neurosciences (NERV)
is a Sell
Is Minerva Neurosciences a Buy, Sell or Hold?
- The current Minerva Neurosciences [NERV] share price is $2.52. The Score for NERV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NERV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Calidi Biotherapeutics (CLDI)
is a Buy
Is Calidi Biotherapeutics a Buy, Sell or Hold?
- The current Calidi Biotherapeutics [CLDI] share price is $0.23. The Score for CLDI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- CLDI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NERV Stock Price Chart
What is Minerva Neurosciences's stock price today?
-
The Minerva Neurosciences share price today is $2.52
The current trend is relatively stagnant and NERV is experiencing slight buying pressure.
CLDI Stock Price Chart
What is Calidi Biotherapeutics's stock price today?
-
The Calidi Biotherapeutics share price today is $0.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDI is experiencing slight selling pressure.
NERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 46.98 | Sell |
Chaikin Money Flow: | -291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.39 - 2.53) | Buy |
Bollinger Bands (100): | (1.99 - 7.75) | Sell |
CLDI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 41.5 | Sell |
Chaikin Money Flow: | -110267 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.14 - 0.3) | Buy |
Bollinger Bands (100): | (0.29 - 1.09) | Sell |
NERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.5 | Buy |
20-day SMA: | 2.46 | Buy |
50-day SMA: | 2.54 | Sell |
200-day SMA: | 5.82 | Sell |
8-day EMA: | 2.5 | Buy |
20-day EMA: | 2.5 | Buy |
50-day EMA: | 3.04 | Sell |
200-day EMA: | 4.97 | Sell |
CLDI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.23 | Sell |
20-day SMA: | 0.2 | Buy |
50-day SMA: | 0.4 | Sell |
200-day SMA: | 2.56 | Sell |
8-day EMA: | 0.23 | Sell |
20-day EMA: | 0.25 | Sell |
50-day EMA: | 0.41 | Sell |
200-day EMA: | 2.62 | Sell |
Minerva Neurosciences Earnings Growth & NERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.49 per share, and a decrease next year of $1.83 per share.
Calidi Biotherapeutics Earnings Growth & CLDI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.29 per share.
Minerva Neurosciences Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Calidi Biotherapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |